Celyad Oncology SA American Depositary Shares
CYAD
CYAD was delisted on the 18th of May, 2023.
7 hedge funds and large institutions have $1.49M invested in Celyad Oncology SA American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
73% less capital invested
Capital invested by funds: $5.46M → $1.49M (-$3.97M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$960K |
| 2 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$67.7K |
| 3 |
Morgan Stanley
New York
|
+$5.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$4M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$4.99K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ECM
1
Endurant Capital Management
San Mateo,
California
| $845K | +$960K | +160,691 | New |
|
|
2
Victory Capital Management
San Antonio,
Texas
| $419K | -$4M | -670,014 | -89% |
|
|
3
Morgan Stanley
New York
| $129K | +$5.38K | +900 | +4% |
|
|
OMC
4
Old Mission Capital
Chicago,
Illinois
| $60K | +$67.7K | +11,323 | New |
|
5
Wells Fargo
San Francisco,
California
| $34K | – | – | – |
|
|
6
UBS Group
Zurich,
Switzerland
| $6K | -$4.99K | -835 | -44% |
|
|
7
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$1K | -87 | Closed |
|
CYAD Hedge Fund Activity: Q2 2021 in Review
7 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Celyad Oncology SA American Depositary Shares (CYAD) for Q2 2021, worth a combined $1.49M — down 73% from $5.46M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CYAD positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Endurant Capital Management, opening a new position worth an estimated $960K. The largest seller was Victory Capital Management, cutting an estimated $4M.
- 7 institutional investors held Celyad Oncology SA American Depositary Shares (CYAD) as of Q2 2021, up from 6 in Q1 2021.
- Funds reported $1.49M of Celyad Oncology SA American Depositary Shares stock for Q2 2021, down 73% quarter-over-quarter.
- 2 funds opened new Celyad Oncology SA American Depositary Shares positions in Q2 2021 and 1 closed out, a net change of +1 holder.
- The largest Celyad Oncology SA American Depositary Shares buyer in Q2 2021 was Endurant Capital Management, an estimated $960K added.
- The largest Celyad Oncology SA American Depositary Shares seller in Q2 2021 was Victory Capital Management, an estimated $4M sold.
Based on aggregated 13F filings for Q2 2021.